Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Inventory (2016 - 2025)

National Healthcare's Inventory history spans 16 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Inventory fell 13.76% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 13.76%, while the annual FY2025 figure was $7.8 million, 13.76% down from the prior year.
  • Inventory reached $7.8 million in Q4 2025 per NHC's latest filing, down from $7.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $9.0 million in Q4 2024 to a low of $6.6 million in Q2 2024.
  • Average Inventory over 5 years is $7.7 million, with a median of $7.8 million recorded in 2024.
  • Peak YoY movement for Inventory: decreased 19.1% in 2023, then rose 22.38% in 2024.
  • A 5-year view of Inventory shows it stood at $8.6 million in 2021, then fell by 17.41% to $7.1 million in 2022, then increased by 4.2% to $7.4 million in 2023, then increased by 22.38% to $9.0 million in 2024, then dropped by 13.76% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's Inventory are $7.8 million (Q4 2025), $7.8 million (Q3 2025), and $7.9 million (Q2 2025).